Generic drugs in cardiology: will they reduce health care costs?

Journal of the American College of Cardiology
Bertram Pitt

Abstract

The introduction of generic drugs should lower health care costs by reducing the price of drugs. The realization of this goal may, however, not be fully achieved: generic drugs may be underused or misused in comparison to prescription drugs because of a lack of ongoing postgraduate physician education. More importantly, there is little incentive to explore new indications for soon-to-be generic drugs and drugs that are already generic. The failure to explore new indications for soon-to-be and existing generic drugs may result in a missed opportunity to further reduce health care costs. Thus, the apparent savings resulting from the introduction of generic drugs may not be fully realized unless the government and other third-party payers take a more active role in postgraduate drug education and investigation.

References

Dec 31, 1997·Archives of Internal Medicine·R S StaffordD Blumenthal
Apr 25, 2000·Lancet·B GeorgesM Jadoul
Jan 22, 2003·Journal of the American College of Cardiology·Biykem BozkurtA A Knowlton
Apr 16, 2003·Circulation·Robert L FryeUNKNOWN Bypass Angioplasty Revascularization Investigation

❮ Previous
Next ❯

Citations

Feb 1, 2007·International Journal of Clinical Practice·B Pitt
Nov 3, 2009·The Journal of Clinical Hypertension·William J Kostis, John B Kostis
Jan 27, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Nicole CurtisJohn W Devlin
Jan 6, 2011·Health Economics, Policy, and Law·Toshiaki Iizuka, Kensuke Kubo
Mar 16, 2007·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Maya GuglinHema Vankayala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.